The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
Open accessAbstract
BACKGROUND: Individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular diseases, osteoporosis, and muscle wasting. Systemic inflammation may be involved in the pathogenesis of these disorders. A study was undertaken to determine whether systemic inflammation is present in stable COPD. METHODS: A systematic review was conducted of studies which reported on the relationship between COPD, forced expiratory volume in 1 second (FEV(1)) or forced vital capacity (FVC), and levels of various systemic inflammatory markers: C-reactive protein (CRP), fibrinogen, leucocytes, tumour necrosis factor-alpha (TNF-alpha), and interleukins 6 and 8. Where possible the results were pooled together to produce a summary estimate using a random or fixed effects model. RESULTS: Fourteen original studies were identified. Overall, the standardised mean difference in the CRP level between COPD and control subjects was 0.53 units (95% confidence interval (CI) 0.34 to 0.72). The standardised mean difference in the fibrinogen level was 0.47 units (95% CI 0.29 to 0.65). Circulating leucocytes were also higher in COPD than in control subjects (standardised mean difference 0.44 units (95% CI 0.20 to 0.67)), as were serum TNF-alpha levels (standardised mean difference 0.59 units (95% CI 0.29 to 0.89)). CONCLUSIONS: Reduced lung function is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“16 As a sensitivity analysis we also pooled the data together using a weighted mean difference technique.”
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“48 49 In view of their potential relevance in COPD, more studies are needed in the future to determine whether the systemic expression of these cytokines is increased in COPD.”
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1843cc · Cited by 1,032
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
The Relationship Between Reduced Lung Function and Cardiovascular Mortality
Sin, D. D., Wu, L., & Man, S. F. P. (2005) · Chest · doi:10.1378/chest.127.6.1952 · Cited by 881
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Vestbo, J., Anderson, W., Coxson, H. O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D. A., MacNee, W., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00111707 · Cited by 759
Marin, J. M., Soriano, J. B., Carrizo, S. J., Boldova, A., & Celli, B. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1869oc · Cited by 699
O’Donnell, D. E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Complex chronic comorbidities of COPD
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00114307 · Cited by 660
Acute-phase proteins: As diagnostic tool
Jain, S., Gautam, V., & Naseem, S. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76489 · Cited by 652
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Chung, K. F., & Adcock, I. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00018908 · Cited by 599
Inflammatory Disease Processes and Interactions with Nutrition
Calder, P. C., Albers, R., Antoine, J.-M., Blum, S., Bourdet-Sicard, R., Ferns, G. A., Folkerts, G., Friedmann, P. S., Frost, G. S., Guarner, F., et al. (2009) · British Journal of Nutrition · doi:10.1017/s0007114509377867 · Cited by 568
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Sidney, S., Sorel, M., Quesenberry, C. P., DeLuise, C., Lanes, S., & Eisner, M. D. (2005) · Chest · doi:10.1378/chest.128.4.2068 · Cited by 540
Cellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 511
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 488
Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., & Make, B. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-148et · Cited by 478
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Feary, J. R., Rodrigues, L. C., Smith, C. J., Hubbard, R. B., & Gibson, J. E. (2010) · Thorax · doi:10.1136/thx.2009.128082 · Cited by 445
Raised CRP levels mark metabolic and functional impairment in advanced COPD
Broekhuizen, R. (2005) · Thorax · doi:10.1136/thx.2005.041996 · Cited by 439
Hypoxemia in patients with COPD: cause, effects, and disease progression
McNicholas, W., Kent, & Mitchell (2011) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10611 · Cited by 434
Physical activity and modulation of systemic low-level inflammation
Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429
Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
Thomsen, M., Ingebrigtsen, T. S., Marott, J. L., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2013) · JAMA · doi:10.1001/jama.2013.5732 · Cited by 401
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man, S. F. P. (2006) · Thorax · doi:10.1136/thx.2006.059808 · Cited by 397
Sinden, N. J., & Stockley, R. A. (2010) · Thorax · doi:10.1136/thx.2009.130260 · Cited by 379
Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease
Edwards, M. R., Bartlett, N. W., Clarke, D., Birrell, M., Belvisi, M., & Johnston, S. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.003 · Cited by 375
“COPD exacerbations are also related to an increase in systemic inflammatory molecules, including c-reactive protein and TNF-α (Gan et al., 2004).”
BackgroundCardiovascular Comorbidity in COPD
Müllerova, H., Agusti, A., Erqou, S., & Mapel, D. W. (2013) · Chest · doi:10.1378/chest.12-2847 · Cited by 358
Reduced Exposure to PM 10 and Attenuated Age-Related Decline in Lung Function
Downs, S. H., Schindler, C., Liu, L.-J. S., Keidel, D., Bayer-Oglesby, L., Brutsche, M. H., Gerbase, M. W., Keller, R., Künzli, N., Leuenberger, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073625 · Cited by 356
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346
Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Morgan, A. D., Zakeri, R., & Quint, J. K. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465817750524 · Cited by 337
Nutritional supplementation for stable chronic obstructive pulmonary disease
Ferreira, I. M., Brooks, D., White, J., & Goldstein, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000998.pub3 · Cited by 326
Le Jemtel, T. H., Padeletti, M., & Jelic, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.046 · Cited by 324
Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease
Savale, L., Chaouat, A., Bastuji-Garin, S., Marcos, E., Boyer, L., Maitre, B., Sarni, M., Housset, B., Weitzenblum, E., Matrat, M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1398oc · Cited by 322
COPD and its comorbidities: Impact, measurement and mechanisms
Negewo, N. A., Gibson, P. G., & McDonald, V. M. (2015) · Respirology · doi:10.1111/resp.12642 · Cited by 311
Diesel exhaust: current knowledge of adverse effects and underlying cellular mechanisms
Steiner, S., Bisig, C., Petri-Fink, A., & Rothen-Rutishauser, B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1736-5 · Cited by 311
Jansen, K. L., Larson, T. V., Koenig, J. Q., Mar, T. F., Fields, C., Stewart, J., & Lippmann, M. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8153 · Cited by 306
Obesity and the lung: 5 {middle dot} Obesity and COPD
Franssen, F. M. E., O'Donnell, D. E., Goossens, G. H., Blaak, E. E., & Schols, A. M. W. J. (2008) · Thorax · doi:10.1136/thx.2007.086827 · Cited by 302
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
de Torres, J. P., Cordoba-Lanus, E., López-Aguilar, C., Muros de Fuentes, M., Montejo de Garcini, A., Aguirre-Jaime, A., Celli, B. R., & Casanova, C. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00109605 · Cited by 297
Decramer, M., Rennard, S., Troosters, T., Mapel, D. W., Giardino, N., Mannino, D., Wouters, E., Sethi, S., & Cooper, C. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 295
Systemic Effects of Chronic Obstructive Pulmonary Disease
Agustí, A. G. N. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-026sr · Cited by 292
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
Current status of research on osteoporosis in COPD: a systematic review
Graat-Verboom, L., Wouters, E. F. M., Smeenk, F. W. J. M., van den Borne, B. E. E. M., Lunde, R., & Spruit, M. A. (2009) · European Respiratory Journal · doi:10.1183/09031936.50130408 · Cited by 290
Grootendorst, D. C., Gauw, S. A., Verhoosel, R. M., Sterk, P. J., Hospers, J. J., Bredenbroker, D., Bethke, T. D., Hiemstra, P. S., & Rabe, K. F. (2007) · Thorax · doi:10.1136/thx.2006.075937 · Cited by 286
Agusti, À., & Soriano, J. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941349 · Cited by 276
Ectopic lymphoid tissues and local immunity
Carragher, D. M., Rangel-Moreno, J., & Randall, T. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.12.004 · Cited by 274
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Feghali-Bostwick, C. A., Gadgil, A. S., Otterbein, L. E., Pilewski, J. M., Stoner, M. W., Csizmadia, E., Zhang, Y., Sciurba, F. C., & Duncan, S. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-014oc · Cited by 269
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
Finkelstein, J., Cha, E., & Scharf, S. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s6400 · Cited by 267
Statin use is associated with reduced mortality in COPD
Søyseth, V., Brekke, P. H., Smith, P., & Omland, T. (2007) · European Respiratory Journal · doi:10.1183/09031936.00106406 · Cited by 267
Agustí, A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-004fm · Cited by 265
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 265
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
EPI-SCAN Steering Committee, Garcia-Rio, F., Miravitlles, M., Soriano, J. B., Muñoz, L., Duran-Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-63 · Cited by 264
Cardiovascular Disease in COPD
Maclay, J. D., & MacNee, W. (2013) · Chest · doi:10.1378/chest.12-0938 · Cited by 257
Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice
Bracke, K. R., D’hulst, A. I., Maes, T., Moerloose, K. B., Demedts, I. K., Lebecque, S., Joos, G. F., & Brusselle, G. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4350 · Cited by 254
Pulmonary Function and Abdominal Adiposity in the General Population
Ochs-Balcom, H. M., Grant, B. J. B., Muti, P., Sempos, C. T., Freudenheim, J. L., Trevisan, M., Cassano, P. A., Iacoviello, L., & Schünemann, H. J. (2006) · Chest · doi:10.1378/chest.129.4.853 · Cited by 253
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease
Hussain, S., Cheol, K., & Mofarrahi, M. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s4480 · Cited by 224
Renna, M. E., O'Toole, M. S., Spaeth, P. E., Lekander, M., & Mennin, D. S. (2018) · Depression and Anxiety · doi:10.1002/da.22790 · Cited by 220
Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease
Plant, P. J., Brooks, D., Faughnan, M., Bayley, T., Bain, J., Singer, L., Correa, J., Pearce, D., Binnie, M., & Batt, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0382oc · Cited by 190
Phenotyping primary human microglia: tight regulation of LPS responsiveness
Melief, J., Koning, N., Schuurman, K. G., Van De Garde, M. D. B., Smolders, J., Hoek, R. M., Van Eijk, M., Hamann, J., & Huitinga, I. (2012) · Glia · doi:10.1002/glia.22370 · Cited by 146
Hypoxaemia Enhances Peripheral Muscle Oxidative Stress in Chronic Obstructive Pulmonary Disease
Koechlin, C. (2005) · Thorax · doi:10.1136/thx.2004.037531 · Cited by 143
Frailty phenotypes and mortality after lung transplantation: a prospective cohort study
Singer, J. P., Diamond, J. M., Anderson, M. R., Katz, P. P., Covinsky, K., Oyster, M., Blue, T., Soong, A., Kalman, L., Shrestha, P., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14873 · Cited by 133
Undernutrition in Patients with COPD and Its Treatment
Itoh, M., Tsuji, T., Nemoto, K., Nakamura, H., & Aoshiba, K. (2013) · Nutrients · doi:10.3390/nu5041316 · Cited by 131
“is generally recognized as a systemic inflammatory disorder not involving the lungs alone, and is characterized by increased production of inflammatory cytokines such as interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α, and also of chemokines [13,14].”
BackgroundTNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia?
Remels, A. H. V., Gosker, H. R., Schrauwen, P., Hommelberg, P. P. H., Sliwinski, P., Polkey, M., Galdiz, J., Wouters, E. F. M., Langen, R. C. J., & Schols, A. M. W. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-150714 · Cited by 122
Crul, T., Spruit, M. A., Gayan‐Ramirez, G., Quarck, R., Gosselink, R., Troosters, T., Pitta, F., & Decramer, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01867.x · Cited by 117
Role of Autophagy in COPD Skeletal Muscle Dysfunction
Hussain, S. N. A., & Sandri, M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2012 · Cited by 77
Case, S. M., & Stewart, J. C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.004 · Cited by 63
Ye, Z., Ai, X., Liao, Z., You, C., & Cheng, Y. (2019) · Medicine · doi:10.1097/md.0000000000016371 · Cited by 57
Cunha, T. F., Bechara, L. R. G., Bacurau, A. V. N., Jannig, P. R., Voltarelli, V. A., Dourado, P. M., Vasconcelos, A. R., Scavone, C., Ferreira, J. C. B., & Brum, P. C. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00182.2016 · Cited by 51
Muscle fatigue resistance during stimulated contractions is reduced in young male smokers
Morse, C. I., Wüst, R. C. I., Jones, D. A., De Haan, A., & Degens, H. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01721.x · Cited by 45
TNF-α Is Associated with Loss of Lean Body Mass Only in Already Cachectic COPD Patients
Eagan, T. M., Gabazza, E. C., D’Alessandro-Gabazza, C., Gil-Bernabe, P., Aoki, S., Hardie, J. A., Bakke, P. S., & Wagner, P. D. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-48 · Cited by 39
“Inflammation and loss of FFMI COPD is a chronic inflammatory disorder, and several studies have found increased levels of TNF-α, as well as CRP and IL-6 both in bronchoalveolar lavage (BAL) [26] and in the systemic circulation [26,27].”
BackgroundCardim, A. B., Marinho, P. E., Nascimento, J. F., Fuzari, H. K., & Dornelas de Andrade, A. (2016) · Respiratory Care · doi:10.4187/respcare.04763 · Cited by 32
Sin, D. D., & Man, S. F. P. (2008) · Chest · doi:10.1378/chest.07-2085 · Cited by 25
Barros, S. P., Suruki, R., Loewy, Z. G., Beck, J. D., & Offenbacher, S. (2013) · PLoS ONE · doi:10.1371/annotation/066cd415-327b-41cb-adce-3db7e5cb527d · Cited by 19
Geletzke, A. K., Rinaldi, J. M., Phillips, B. E., Mobley, S. B., Miller, J., Dykes, T., Hollenbeak, C., Kelleher, S. L., & Soybel, D. I. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2431-y · Cited by 14
Robison, P., Sussan, T. E., Chen, H., Biswal, S., Schneider, M. F., & Hernández-Ochoa, E. O. (2017) · Muscle & Nerve · doi:10.1002/mus.25466 · Cited by 14
Metadata
- Authors
- Gan, W. Q.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2004-07-01
- Volume
- 59
- Issue
- 7
- Pages
- 574-580
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2104168490
- Cited by
- 1,838
- References
- 51
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.